Pediatric Ulcerative Colitis
6
0
0
2
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
11 treatments under study, led by Group Educational Activities
Research Leaders
10 sponsors active, led by Alberta Children's Hospital
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
33.3%
2 terminated out of 6 trials
50.0%
-36.6% vs benchmark
17%
1 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
Peer Mentoring to Improve Self-management in Youth With IBD
Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
Exercise Training in Youth With Inflammatory Bowel Disease
Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis
Mission is Remission®: How Can a Disease Self-management Website Change Care?
Research Network
Common Treatments
- Group Educational Activities1
- Ibd Educational Website1
- Monthly Checkin Calls From Program Coordinator1
- Exercise Training Program1
- Fun Group Activities1
Active Sponsors
- Alberta Children's Hospital1
- Stollery Children's Hospital1
- Kelly Boone1
- Tanabe Pharma Corporation1
- Cardiff and Vale University Health Board1
Top Investigators
McMaster University
IWK Health Centre
Kitasato University Kitasato Institute Hospital
Cardiff and Vale University Health Board
ReveraGen BioPharma
Related Conditions
- Pediatric Crohns Disease4
- Inflammatory Bowel Diseases2
- Pediatric Inflammatory Bowel Diseases1
- Ulcerative Colitis1
- Crohn Disease1